Recothrom Market Report 2026

Recothrom Market Overview

• The Recothrom market growth in the historic period has been driven by increasing use of thrombin in surgical procedures, growing adoption in vascular and orthopedic surgeries • Market expansion is supported by increasing demand for plasma-free hemostatic solutions, rising focus on infection risk reduction • Growth Driver: Growth Of Surgical Procedures Driving Expansion Of The Market • Market Trend: Advancements In Flowable Hemostats For Surgical Safety • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Recothrom Market?

Recothrom is a recombinant thrombin product used in surgeries to control bleeding by promoting clot formation. It is a topical hemostat that works by promoting clot formation, helping to stop bleeding in a localized area. Recothrom is commonly used in surgeries where bleeding may occur, such as in vascular, liver, or orthopedic procedures. The main indications of recothrom are surgical procedures and trauma management. Surgical procedures refer to medical operations performed to treat or diagnose conditions by making incisions or using specialized instruments. It is formulated in powder form and solution form and is distributed through various channels such as direct sales, distributors, and online sales catering to various end users such as hospitals, ambulatory surgical centers, and tactical combat casualty care.

What Is The Recothrom Market Growth Forecast?

The growth in the forecast period can be attributed to increasing demand for plasma-free hemostatic solutions, rising focus on infection risk reduction, expansion of emergency and trauma care services, growing adoption in ambulatory surgery centers, increasing investment in recombinant biologics manufacturing. Major trends in the forecast period include increasing adoption of recombinant hemostatic agents, rising use of topical thrombin products, growing demand for rapid surgical bleeding control, expansion of hemostats in trauma care, enhanced focus on biologic safety and purity.

Global Recothrom Market Segmentation

1) By Indication: Surgical Procedures, Trauma Management 2) By Formulation: Powder Form, Solution Form 3) By Distribution Channel: Direct Sales, Distributors, Online Sales 4) By End User: Hospitals, Ambulatory Surgical Centers, Tactical Combat Casualty Care

What Are The Drivers Of The Recothrom Market?

The increase in surgical procedures is expected to propel the growth of the recothrom market going forward. A surgical procedure is a medical operation performed by a surgeon to treat or diagnose a health condition, often involving incisions, tissue removal or repair, or the use of instruments to correct bodily issues. The increase in surgical procedures is driven by the rising prevalence of chronic diseases, aging populations, and advancements in medical technology and minimally invasive techniques, which have improved patient outcomes and encouraged more surgeries. Recothrom helps control bleeding during surgical procedures by promoting clot formation and enhancing the natural blood coagulation process for faster hemostasis. For instance, in August 2024, according to the National Library of Medicine, a US-based biomedical library, in 2023, there was a 3.4% increase in the global volume of aesthetic procedures, with a total of 34.9 million surgical and nonsurgical procedures conducted by plastic surgeons. This included over 15.8 million surgical procedures and more than 19.1 million nonsurgical treatments performed worldwide. Therefore, the increase in surgical procedures is driving the growth of the recothrom industry. The rising healthcare investments are expected to propel the growth of the recothrom market going forward. Healthcare investments refer to the allocation of financial resources into the healthcare sector, aiming to generate a return or support growth in various areas such as medical research, healthcare services, pharmaceuticals, biotechnology, healthcare technology, and more. The rising healthcare investments can be attributed to factors such as an aging population, advancements in medical technology, increasing healthcare costs, and the growing demand for innovative treatments and services. Healthcare investments support recothrom by providing a recombinant thrombin solution that improves surgical outcomes and minimizes complications, making it a valuable tool in medical procedures. For instance, in November 2025, according to the Organisation for Economic Co-operation and Development, a France-based intergovernmental organization, reported that in 2024, average health spending in OECD countries was estimated to stand at nearly USD 6 000 per capita (when adjusted for differences in purchasing power). Therefore, rising healthcare investments are driving the growth of the recothrom industry.

Key Players In The Global Recothrom Market

Major companies operating in the recothrom market are Baxter International Inc.

Global Recothrom Market Trends and Insights

Major companies operating in the recothrom market are focusing on developing innovative solutions, such as flowable hemostats, to meet the rising demand for faster, safer, and more efficient surgical bleeding control. Flowable hemostats are gel-based agents designed to conform to complex anatomical areas where traditional hemostatic methods may be less effective. For instance, in April 2023, Baxter International Inc., a US-based healthcare company, launched Floseal + Recothrom, an innovative flowable hemostat introduced after 2022. The product combines a flowable gelatin-based matrix with recombinant thrombin produced using recombinant DNA technology. It eliminates the need for human blood components, improving safety. The formulation delivers faster preparation, over 1.5× quicker than traditional agents, while enhancing hemostasis efficiency during surgical procedures.

Regional Insights

North America was the largest region in the recothrom market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Recothrom Market?

The recothrom market consists of sales of surgical hemostats, hemostatic sponges, fibrin sealants, single-dose vials, and lyophilized powder. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Recothrom Market Report 2026?

The recothrom market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the recothrom industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.